About EDAP TMS Investors Information Products & Services Clinical Information Press Careers Home / Press / news News OCT 7, 2021 Beyond Death Valley: Medtech Veteran Breathes New Life into HIFU Company Ryan Rhodes, new CEO of EDAP USA was featured in MDDI this week. Rhodes hales from Intuitive Surgical where he helped build the DaVinci Robot brand. He compares HIFU to the early days of robotic surgery: “The HIFU market is still in its infancy, and Rhodes said it reminds him of his early days at Intuitive Surgical, when the Irvine, CA-based robotics company was focused on prostate cancer, specifically radical prostatectomy, which was also a very young market at the time.” Read more SEP 7, 2021 EDAP's HIFU Progress Is Obscured By The Pandemic, But It's Real Very positive article on EDAP’s future and its advances on #HIFU, written by Seeking Alpha. Read more JUN 15, 2021 EDAP Announces Hiring of MedTech Industry Veteran Ryan Rhodes as CEO of Company’s U.S. Subsidiary LYON, France, June 15, 2021 -- EDAP TMS SA, the global leader in robotic energy-based therapies, announced today that the company has hired medical technology industry veteran Ryan Rhodes as Chief Executive Officer of EDAP Technomed, the Company’s U.S. subsidiary. Read more MAY 9, 2021 In the C-Suite with Marc Oczachowski, CEO, EDAP TMS We venture to Lyon, France to learn how Marc and his team fresh off a $28 million raise are setting the stage to dominate High Intensity Focused Ultrasound (HIFU) for prostate cancer. Read more MAR 3, 2021 EDAP Selects Leading Reimbursement Consultancies MTP and Argenta Advisors to Expand Market Access and Coverage of HIFU in the US EDAP TMS, the global leader in robotic energy-based therapies, announces today that the company has selected Medical Technology Partners (MTP) and Argenta Advisors, two leading reimbursement consultancies, to further expand coverage, accelerate market access and secure future payment rates for the company’s Focal One high intensity focused ultrasound (HIFU) procedure in the US. The announcement follows the establishment of a Category 1 CPT code, and physician reimbursement for HIFU, that went into effect on January 1, 2021. Read more FEB 18, 2021 The Future Is Now: Marc Oczachowski of EDAP TMS On How Their Technological Innovation Will Shake Up Healthcare Marc Oczachowski is Chairman of the Board and Chief Executive Officer of EDAP TMS, a high-tech medical company which develops, manufactures markets minimally invasive therapeutic ultrasound solutions for urology, tumor removal, localized prostate cancer, and infectious diseases. Read more JAN 14, 2021 Positive 24 month interim results of French Urology Association (AFU) sponsored clinical trial study comparing HIFU to radical prostate surgery Positive 24 month interim results of French Urology Association (AFU) sponsored clinical trial study comparing HIFU to radical prostate surgery: results on 3,329 patients demonstrate significant difference in efficacy in favor of HIFU versus Radical Prostatectomy (RP). Read more DEC 17, 2020 By bringing a safe, ambulatory and non-invasive solution to patients with #prostate conditions, watch how EDAP TMS and #HIFU users are handling the situation with COVID-19 when elective procedures are currently being put on-hold. EDAP TMS and #HIFU users are handling the situation with COVID-19 when elective procedures are currently being put on-hold. Read more DEC 9, 2020 Final US 2021 reimbursement rules for High Intensity Focused Ultrasound (HIFU) U.S. Centers for Medicare and Medicaid Services (CMS) has issued its final rules establishing, for the first time, a Category 1 CPT code which facilitates reimbursement for the ablation of malignant prostate tissue with HIFU technology, effective January 1, 2021. Read more SEP 3, 2020 First patients treated in phase 2 study of Focal One for the treatment of deep invasive endometriosis the first two patients have been treated in the company’s Phase 2 clinical trial assessing Focal One® High Intensity Focused Ultrasound (HIFU) as a potential treatment for deep rectal endometriosis. A total of 38 women will be enrolled in the study and treated at five major hospitals and assessed over a six-month follow-up period. Read more AUG 25, 2020 Approval received for phase II study evaluating HIFU for deep invasive endometriosis EDAP TMS has received approval from French health authorities to initiate a Phase II multicenter clinical trial evaluating its Focal One® HIFU to treat deep rectal endometriosis. Read more AUG 18, 2020 Two publications highlighting favorable HIFU focal therapy outcomes in journal of urology Studies conducted at the University of Southern California and University of Miami represent the first U.S. publications detailing successful partial-gland ablation using high intensity focused ultrasound therapy to treat prostate cancer patients since FDA cleared the technology in 2015. Read more AUG 18, 2020 Two publications highlighting favorable HIFU focal therapy outcomes in journal of urology Studies conducted at the University of Southern California and University of Miami represent the first U.S. publications detailing successful partial-gland ablation using high intensity focused ultrasound therapy to treat prostate cancer patients since FDA cleared the technology in 2015. Read more JUL 15, 2020 EDAP Announces Recent Focal One Sales Successes Company completes four Focal One sales, including three bundled sales that combine Focal One® with Exact Imaging’s ExactVu micro ultrasound imaging solution. Read more MAY 12, 2020 EDAP announces exclusive worldwide distribution rights to EXACT Imaging's Micro-Ultrasound Technologies EDAP announces exclusive worldwide distribution rights to EXACT Imaging's Micro-Ultrasound Technologies Read more APR 23, 2020 B Riley FBR Initiates Research Coverage on EDAP TMS Last week Andrew D’Silva of B Riley FBR launched research coverage on EDAP TMS with a buy-rating and price target at $5.50. Read more MAR 17, 2020 EDAP TMS about COVID-19 Update on COVID-19 and the Potential Impact to Operations Read more APR 1, 2019 Focal One's precision means qualifying prostate cancer patients can forego prostate removal surgery and avoid life-altering side effects including incontinence and impotence The University of Chicago Medicine became the first medical center in the Midwest to offer focal therapy to men with localized prostate cancer, using Focal One, the only advanced robotic ultrasound technology available to target and ablate diseased prostate tissue. Read more MAR 4, 2019 Houston Methodist's Reinforces EDAP's Position as a Leading HIFU Innovator Houston Methodist Hospital, has acquired Focal One®, the most advanced HIFU technology available today Read more JAN 23, 2019 Maimonides Medical Center acquires Focal One Technology Maimonides Medical Center acquires Focal One Technology Read more JAN 14, 2019 Two additional Focal One devices to two leading hospitals in Brazil Hospital 9 de Julho and Hospital Moriah join growing roster of highly-regarded hospitals in Brazil offering Focal One Read more JAN 3, 2019 John Wayne Cancer Institute First US Medical Center to Acquire EDAP's Breakthrough Focal One Technology for Prostate Tissue Ablation John Wayne Cancer Institute (JWCI) at the Providence Saint John's Health Center in Santa Monica, offer focal therapy to patients with localized prostate cancer using Focal One Read more DEC 12, 2018 Oncology Live - Urologists in Cancer Care Focal Therapy Evolves Into More Precise Treatment Read more NOV 21, 2018 As the Wife of a Prostate Cancer Survivor As the Wife of a Prostate Cancer Survivor I’m Eternally Grateful for Colorado’s Early Blood Draw Read more OCT 26, 2018 A New Treatment for Localized Prostate Cancer Lets Men Keep the Sexual Passion in Their Relationships A New Treatment for Localized Prostate Cancer Lets Men Keep the Sexual Passion in Their Relationships Read more OCT 24, 2018 Urologists, uro-oncologists and urology department chairs from renowned American universities will spend a day at Jewish General Hospital Urologists, uro-oncologists and urology department chairs from renowned American universities will spend a day at Jewish General Hospital Read more OCT 3, 2018 HIFU Prostate Procedure Helps NASA Safety Engineer Protect His Health HIFU Prostate Procedure Helps NASA Safety Engineer Protect His Health Read more SEP 27, 2018 EDAP TMS SA the global leader in therapeutic ultrasound, today announced the installation of the third Focal One device in Brazil at the renowned Albert Einstein Center of Oncology, EDAP TMS SA the global leader in therapeutic ultrasound, today announced the installation of the third Focal One device in Brazil at the renowned Albert Einstein Center of Oncolog Read more SEP 26, 2018 Prostate Cancer Leads Aerospace Biomedical Technician to Discover High-Tech HIFU Charles McFarland shares his experience with High Intensity Focused Ultrasound treatment of prostate cancer. Read more SEP 20, 2018 EDAP announces Installation of First Focal One HIFU device in South Korea EDAP announces Installation of First Focal One HIFU device in South Korea Read more JUL 30, 2018 Alternative Treatment for Localized Prostate Cancer: Three Men’s Perspectives Alternative Treatment for Localized Prostate Cancer: Three Men’s Perspectives Read more JUL 24, 2018 Less-invasive prostate cancer treatment receives FDA clearance Less-invasive prostate cancer treatment receives FDA clearance Read more JUL 24, 2018 Boomer Times Presents: Anita Finley with Clifford Gluck, MD, urologist Boomer Times Presents: Anita Finley with Clifford Gluck, MD, urologist Read more JUN 20, 2018 University of Miami at Forefront of Prostate Cancer Treatment University of Miami at Forefront of Prostate Cancer Treatment Read more JUN 7, 2018 EDAP Announces FDA Clearance for Focal One EDAP Announces FDA Clearance for Focal One Read more MAY 24, 2018 HIFU Procedure Keeps High School Ref in the Game after Prostate Cancer Diagnosis HIFU Procedure Keeps High School Ref in the Game after Prostate Cancer Diagnosis Read more APR 9, 2018 Focal Ultrasound Prostate Ablation Shows Promising Results with Fewer Side Effects Focal Ultrasound Prostate Ablation Shows Promising Results with Fewer Side Effects Read more APR 9, 2018 Database to follow patients undergoing partial-gland HIFU Database to follow patients undergoing partial-gland HIFU Read more APR 8, 2018 Point: Is HIFU for low-risk prostate Ca ready for prime time? Point: Is HIFU for low-risk prostate Ca ready for prime time? Read more APR 6, 2018 In a First, US Insurer Covers HIFU for Prostate Cancer In a First, US Insurer Covers HIFU for Prostate Cancer Read more APR 3, 2018 EDAP Reports First US Cohort Study Results of Focal HIFU Prostate Ablation Shows Promising Outcomes EDAP Reports First US Cohort Study Results of Focal HIFU Prostate Ablation Shows Promising Outcomes Read more MAR 28, 2018 New prostate cancer treatment found more effective than previous methods New prostate cancer treatment found more effective than previous methods Blair's doctor Dipen Parekh from the University of Miami School of Medicine says that the treatment is new and effective Read more MAR 28, 2018 New Prostate Cancer Treatment Is A Real Life Saver New Prostate Cancer Treatment Is A Real Life Saver Read more MAR 26, 2018 Major US insurer to cover use of HIFU for treatment of radiorecurrent prostate cancer Major US insurer to cover use of HIFU for treatment of radiorecurrent prostate cancer Read more MAR 21, 2018 EDAP Announces CIGNA as First Major U.S. Private Health Insurer to Cover HIFU for Prostate Procedure EDAP Announces CIGNA as First Major U.S. Private Health Insurer to Cover HIFU for Prostate Procedure Read more MAR 6, 2018 Top Universities Join Forces to Launch First U.S. Based HIFU Patient Registry for Prostate Treatment Top Universities Join Forces to Launch First U.S. Based HIFU Patient Registry for Prostate Treatment Read more MAR 5, 2018 How to Build a Business Case for Medical Devices Awaiting Reimbursement How to Build a Business Case for Medical Devices Awaiting Reimbursement Read more MAR 2, 2018 Focusing On You - Interview with Dr. Dipen Parekh Focusing On You - Interview with Dr. Dipen Parekh Read more JAN 26, 2018 Men with Prostate Cancer May Not Know All of Their Treatment Options and Risks Men with Prostate Cancer May Not Know All Of Their Treatment Options and Risks Read more JAN 23, 2018 They may have cancer. But they’ll be at the starting line. They may have cancer. But they’ll be at the starting line. Read more JAN 11, 2018 New Medical Technology Gives Urologists a More Precise Method to Target Diagnosed Areas of the Prostate New Medical Technology Gives Urologists a More Precise Method to Target Diagnosed Areas of the Prostate We asked Dr. Cary Robertson, M.D. from Duke University Medical Center three questions on the latest development of a new medical technology that gives urologists a more precise method for treating prostate cancer. Read more JAN 7, 2018 Impact: Opio Speaks with Dr. Ivan Grunberger about Prostate Cancer Impact: Opio Speaks with Dr. Ivan Grunberger about Prostate Cancer Read more JAN 2, 2018 30 secondes interview with Dr. Brian Miles on KTRH (iHeart Radio) 30 secondes interview with Dr. Brian Miles on KTRH (iHeart Radio) Read more DEC 21, 2017 How to build a business case for medical devices awaiting reimbursement In 2015, Houston Methodist Hospital made the decision to invest in a medical technology that had not yet been approved by the US Food & Drug Administration. Read more DEC 18, 2017 Prostate cancer therapy gives patients a different approach Rochester, N.Y. (WHAM) - A new therapy is giving prostate cancer patients in Rochester an alternative to traditional cancer treatment. Read more DEC 17, 2017 A Health Screening Saved My Life My Journey with Prostate Cancer Treatment Read more DEC 12, 2017 Prostate Cancer 101: What All Senior Men Should Know Prostate cancer is the third most common type of cancer. It affects over 3 million men in the United States – most of them seniors. Read more NOV 29, 2017 Arizona procedure could reduce side effects of prostate cancer treatment PHOENIX — A new treatment for prostate cancer being used in Arizona could reduce the side effects experienced by patients, a doctor said. Read more NOV 28, 2017 Urologic Surgeons AZ Offer New Treatment for Prostate Cancer Mesa Practice is First in Arizona to Use Minimally Invasive HIFU Procedure, Presents Low Risk of Impotence, Incontinence to Patients Read more NOV 14, 2017 Urologic Surgeons of Arizona to Offer New Option to Prostate Cancer Patients Mesa Practice is First in Arizona to Use Minimally Invasive HIFU Procedure, Presents Low Risk of Impotence, Incontinence to Patients Read more NOV 14, 2017 What’s New in HIFU? Advances in Ultrasound Technology Offer New Options to U.S. Prostate Cancer Patients Read more NOV 11, 2017 Deciding to Use HIFU for Prostate Cancer Treatment According to the American Cancer Society, prostate cancer is the most common cancer among men, after skin cancer and there will be 161,360 new diagnoses this year alone. Read more NOV 4, 2017 Four Things Every Man Needs to Know after a Prostate Cancer Diagnosis Men diagnosed with prostate cancer find assurance in discussing the state of their disease and treatment options in detail. Read more NOV 3, 2017 Dr. Bruno Nahar Interview - HIFU Prostate Treatment Watch Dr. Bruno Nahar Interview NOV 2, 2017 Urologic Surgeons of Arizona offers new treatment for prostate cancer Urologic Surgeons of Arizona offers new treatment for prostate cancer Read more OCT 31, 2017 Calls for Early Prostate Cancer Screening of Black Men May Get a Boost From HIFU Technology African American men who delay testing or treatment for prostate cancer run greater risks with their health than other males Read more OCT 9, 2017 Dr. Brian J. Miles interview Dr. Brian J. Miles, Professor of Urology at Weill Cornell Medical College of Cornell University at Houston Methodist Hospital and specializing in urologic oncology, especially cancer of the prostate. Read more SEP 11, 2017 EDAP Announces Filing of New 510K EDAP Announces Filing of New 510(k) Application for Focal One(R) Device Read more SEP 1, 2017 Vituro Health Adds Ablatherm Robotic HIFU EDAP Partners with Leading US HIFU provider, Vituro Health Adds Ablatherm Robotic HIFU Read more MAY 22, 2017 New Reimbursement Code for HIFU Ablation EDAP Announces CMS Approval of New Reimbursement Code for HIFU Ablation of the Prostate Read more FEB 27, 2017 Ablatherm at University of Minnesota EDAP's Ablatherm® Robotic HIFU Treatments Performed at University of Minnesota Read more JAN 23, 2017 EDAP to Exclusively Distribute LABORIE's Medical Measurement Systems EDAP to Exclusively Distribute LABORIE's Medical Measurement Systems Urodynamic Products in Japan Read more DEC 19, 2016 Superior Outcomes of Focal Ablatherm-HIFU EDAP Reports Superior Outcomes of Focal Ablatherm-HIFU Compared to Robotic Radical Prostatectomy Read more DEC 12, 2016 Focal One(R) HIFU Sale to Foch Hospital, Paris EDAP Announces Focal One(R) HIFU Sale to Foch Hospital, Paris Read more DEC 8, 2016 EDAP Receives the Prestigious Prix Galien EDAP Receives the Prestigious Prix Galien for its Focal One(R) HIFU device Read more OCT 13, 2016 Ablatherm(R) Robotic HIFU Positioned as Efficient Option for Unilateral Prostate Ablation EDAP's Ablatherm(R) Robotic HIFU Positioned as Efficient Option for Unilateral Prostate Ablation in Breakthrough Multicenter Study Published in Major Medical Journal Read more SEP 12, 2016 Ablatherm Robotic(R) HIFU at Leading Academic Medical Center EDAP Installs Ablatherm Robotic(R) HIFU at Leading Academic Medical Center Read more AUG 22, 2016 First HIFU patient treated at Henry Ford Hospital in Detroit EDAP's Ablatherm® Robotic HIFU Treats First Patient at Henry Ford Hospital in Detroit Read more JUN 14, 2016 First HIFU patient treated at Allied Urological Services in New York City First HIFU patient treated at Allied Urological Services in New York City with the Ablatherm® Robotic HIFU device Read more JAN 25, 2016 First Prostate Ablation Treatments Performed Using EDAP's FDA Approved Ablatherm® Robotic HIFU First Prostate Ablation Treatments Performed Using EDAP's FDA Approved Ablatherm® Robotic HIFU at Sylvester Comprehensive Cancer Center, in Miami, Florida Read more JAN 19, 2016 EDAP Announces Results of World's First Focal HIFU Trial EDAP Announces Results of World's First Focal HIFU Trial Read more DEC 23, 2015 EDAP Reports Sale of Ablatherm Robotic HIFU to Sylvester Comprehensive Cancer Center EDAP Reports Sale of Ablatherm Robotic HIFU to Sylvester Comprehensive Cancer Center Read more DEC 11, 2015 EDAP Receives Russian Regulatory Approval for Focal One® HIFU Device EDAP Receives Russian Regulatory Approval for Focal One® HIFU Device Read more DEC 9, 2015 Installation of Ablatherm® Robotic HIFU at University of Southern California EDAP Reports Installation of Ablatherm® Robotic HIFU at University of Southern California Read more NOV 12, 2015 EDAP Records First Three U.S. Orders for Ablatherm HIFU EDAP Records First Three U.S. Orders for Ablatherm HIFU Read more NOV 9, 2015 Ablatherm FDA approved EDAP Receives FDA Approval for Ablatherm HIFU Read more SEP 24, 2015 Focal One® HIFU Device Adopted by Medipole Group in France EDAP's Focal One® HIFU Device Adopted by Medipole Group in France Read more JUL 7, 2015 Focal One device in Switzerland EDAP's Focal One® HIFU Device Adopted by Two University Hospitals in Switzerland Read more JUN 9, 2015 Focal One® HIFU at Germany's Martini-Klinik EDAP Announces Focal One® HIFU Installation at Germany's Martini-Klinik Read more MAR 31, 2015 First Focal One® HIFU Device in North America First Focal One® HIFU Device in North America EDAP Announces Sale of First Focal One® HIFU Device in North America Read more MAR 26, 2015 EDAP to Participate in Major EDAP to Participate in Major, Multi-Partner Liver Cancer Development Project Read more MAR 9, 2015 EDAP Announces Plans to Pursue Direct De Novo 510(k) EDAP Announces Plans to Pursue Direct De Novo 510(k) Petition in Lieu of PMA for Its Ablatherm HIFU Read more FEB 26, 2015 EDAP TMS SA today announced a multi-national strategic OEM partnership with Quanta System EDAP TMS SA, today announced a multi-national strategic OEM partnership with Quanta System Read more JAN 9, 2015 Focal One HIFU Device Approved by Health Canada EDAP's Focal One HIFU Device Approved by Health Canada Read more NOV 20, 2014 EDAP Reports Continued Strong Growth in Third Quarter 2014 EDAP Reports Continued Strong Growth in Third Quarter 2014 Read more NOV 6, 2014 EDAP Receives FDA Guidance on PMA for Ablatherm-HIFU EDAP Receives FDA Guidance on PMA for Ablatherm-HIFU Read more OCT 21, 2014 EDAP Announces Sale of Focal One Nantes EDAP Announces Sale of Focal One(R) HIFU Device to Nantes-Atlantis Urology Clinic in France Read more OCT 7, 2014 EDAP Announces Sale of Focal One HIFU Device to Mannheim EDAP Announces Sale of Focal One® HIFU Device to Mannheim University Hospital, Germany Read more SEP 26, 2014 Ablatherm HIFU Technology Highlighted EDAP's Ablatherm® HIFU Technology Highlighted at the World Congress of Endourology, Taiwan Read more JUN 27, 2014 EDAP Completes FDA Inspection of Manufacturing Site FDA Inspector Reported no Findings From the Scheduled Facility Audit. Read more APR 21, 2014 Reimbursement of HIFU EDAP TMS Announces Reimbursement of HIFU Treatment for Prostate Cancer by France's Ministry of Health Read more MAR 20, 2014 EDAP Completes FDA Q&A Session EDAP Completes FDA Q&A Session for Its Ablatherm-HIFU Pre-Market Approval Application Read more FEB 11, 2014 NEWS-First Focal One's treatments in Poland EDAP TMS Delivers Focal One® Device for Focal Treatment of Prostate Cancer to Hospital in Poland. Read more OCT 4, 2013 Arnaud Montebourg en visite à EDAP TMS Arnaud MONTEBOURG, Ministre du redressement productif se rendra à la société EDAP TMS vendredi 4 octobre. Read more Press news Press kit Company A tradition of Innovation EDAP TMS Overview Jobs & Career Contact us Products Focal One® ExactVU® Sonolith® i-move Laserlith® i-dust Services HIFU Services ESWL Services Customer Care Center Training EDAP TMS Websites EDAP TMS Japan HIFU patient web site ©EDAP TMS 2014-2021 Terms of Use Transparence Contact